426 related articles for article (PubMed ID: 11406660)
1. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma.
Sakamoto A; Oda Y; Itakura E; Oshiro Y; Nikaido O; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Jun; 14(6):581-8. PubMed ID: 11406660
[TBL] [Abstract][Full Text] [Related]
2. H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma.
Sakamoto A; Oda Y; Itakura E; Oshiro Y; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2001 Nov; 32(11):1225-31. PubMed ID: 11727262
[TBL] [Abstract][Full Text] [Related]
3. Ultraviolet-induced p53 mutations in atypical fibroxanthoma.
Dei Tos AP; Maestro R; Doglioni C; Gasparotto D; Boiocchi M; Laurino L; Fletcher CD
Am J Pathol; 1994 Jul; 145(1):11-7. PubMed ID: 8030743
[TBL] [Abstract][Full Text] [Related]
4. Atypical fibroxanthoma and malignant fibrous histiocytoma of the skin.
Rizzardi C; Angiero F; Melato M
Anticancer Res; 2003; 23(2C):1847-51. PubMed ID: 12820468
[TBL] [Abstract][Full Text] [Related]
5. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma.
Sakamoto A; Oda Y; Yamamoto H; Oshiro Y; Miyajima K; Itakura E; Tamiya S; Honda Y; Ishihara A; Iwamoto Y; Tsuneyoshi M
Virchows Arch; 2002 Apr; 440(4):404-9. PubMed ID: 11956822
[TBL] [Abstract][Full Text] [Related]
6. Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma.
Ly H; Selva D; James CL; Huilgol SC
Australas J Dermatol; 2004 May; 45(2):106-9. PubMed ID: 15068457
[TBL] [Abstract][Full Text] [Related]
7. Atypical fibroxanthoma and malignant fibrous histiocytoma.
Withers AH; Brougham ND; Barber RM; Tan ST
J Plast Reconstr Aesthet Surg; 2011 Nov; 64(11):e273-8. PubMed ID: 21664889
[TBL] [Abstract][Full Text] [Related]
8. Atypical fibroxanthoma versus benign and malignant fibrous histiocytoma. A comparative study of their proliferative activity using MIB-1, DNA flow cytometry, and p53 immunostaining.
Oshiro Y; Fukuda T; Tsuneyoshi M
Cancer; 1995 Mar; 75(5):1128-34. PubMed ID: 7850711
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of the Gadd45 gene at exon 4 in atypical fibroxanthoma.
Sakamoto A; Akieda S; Oda Y; Iwamoto Y; Tsuneyoshi M
BMC Dermatol; 2009 Jan; 9():1. PubMed ID: 19128509
[TBL] [Abstract][Full Text] [Related]
10. CD117 immunoreactivity in atypical fibroxanthoma.
Mathew RA; Schlauder SM; Calder KB; Morgan MB
Am J Dermatopathol; 2008 Feb; 30(1):34-6. PubMed ID: 18212542
[TBL] [Abstract][Full Text] [Related]
11. [Detection of point mutation of p53 gene by silver staining PCR-SSCP in paraffin-embedded malignant fibrous histiocytoma].
Li J; Yang G; Li G
Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):13-5. PubMed ID: 8732103
[TBL] [Abstract][Full Text] [Related]
12. Respective roles of cyclobutane pyrimidine dimers, (6-4)photoproducts, and minor photoproducts in ultraviolet mutagenesis of repair-deficient xeroderma pigmentosum A cells.
Otoshi E; Yagi T; Mori T; Matsunaga T; Nikaido O; Kim ST; Hitomi K; Ikenaga M; Todo T
Cancer Res; 2000 Mar; 60(6):1729-35. PubMed ID: 10749146
[TBL] [Abstract][Full Text] [Related]
13. The distribution of UV photoproducts along the human p53 gene and its relation to mutations in skin cancer.
Tornaletti S; Rozek D; Pfeifer GP
Oncogene; 1993 Aug; 8(8):2051-7. PubMed ID: 8336934
[TBL] [Abstract][Full Text] [Related]
14. Myxoid atypical fibroxanthoma: a previously undescribed variant.
Patton A; Page R; Googe PB; King R
J Cutan Pathol; 2009 Nov; 36(11):1177-84. PubMed ID: 19320792
[TBL] [Abstract][Full Text] [Related]
15. Atypical fibrous histiocytoma and atypical fibroxanthoma: presentation of two cases.
Kram A; Stańczyk J; Woyke S
Pol J Pathol; 2003; 54(4):267-71. PubMed ID: 14998296
[TBL] [Abstract][Full Text] [Related]
16. CD99 immunoreactivity in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma: a useful diagnostic marker.
Hartel PH; Jackson J; Ducatman BS; Zhang P
J Cutan Pathol; 2006 Sep; 33 Suppl 2():24-8. PubMed ID: 16972949
[TBL] [Abstract][Full Text] [Related]
17. Histiocyte-like cells expressing factor XIIIa do not belong to the neoplastic cell population in malignant fibrous histiocytoma.
Szollosi Z; Nemeth T; Egervari K; Nemes Z
Pathol Res Pract; 2005; 201(5):369-77. PubMed ID: 16047946
[TBL] [Abstract][Full Text] [Related]
18. Atypical fibroxanthoma: DNA ploidy analysis of 14 cases with possible histogenetic implications.
Worrell JT; Ansari MQ; Ansari SJ; Cockerell CJ
J Cutan Pathol; 1993 Jun; 20(3):211-5. PubMed ID: 8396160
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
de Feraudy S; Mar N; McCalmont TH
Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
